Table 2.

Overview of the INKA study

Examination/point in time	Inclusion	Prior to chemotherapy	Prior to RT	During RT	Finish of RT	Week 8 preop.	Week 13-15	Month 6
Medical history	x		x		x	x	x	x
FeV1	x					x	x	x
Assessment of toxicity			x	x	x	x	x	x
Blood count	x	x	x	x	x	x	x
FDG-PET-CT						x
CT with i.v. contrast	x					x	x	x
Quality of life EORTC QLQ-C30, LC13		x	x			x	x	x